Fluocinolone acetonide
Effect of fluocinolone acetonide 0.2 μg/day implant on the decision to drive in patients with diabetic macular oedema: a report from the FAME study
6
Cost effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies
14
Surgical management of fibrotic encapsulation of the fluocinolone acetonide implant in <em>CAPN5</em>-associated proliferative vitreoretinopathy
6
Fluocinolone acetonide intravitreal sustained release device – a new addition to the armamentarium of uveitic management
10
Injectable 0.19-mg fluocinolone acetonide intravitreal implant for the treatment of non-infectious uveitic macular edema
9
The efficacy and safety outcomes of the 0.19 mg fluocinolone acetonide implant after prior treatment with the 0.7 mg dexamethasone implant in patients with diabetic macular edema
5
STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF SIMULTANEOUS ESTIMATION OF CIPROFLOXACIN AND FLUOCINOLONE ACETONIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM
14
Clinical utility of intravitreal fluocinolone acetonide (Iluvien<sup>®</sup>) implant in the management of patients with chronic diabetic macular edema: a review of the current literature
8
Long-term follow-up of patients treated with multiple fluocinolone acetonide implants for noninfectious uveitis
6
Fluocinolone acetonide and its potential in the treatment of chronic diabetic macular edema
7
Treating Diabetic Macular Oedema (DMO): real world UK clinical outcomes for the 0.19mg Fluocinolone Acetonide intravitreal implant (Iluvien™) at 2 years
7
<p>Effectiveness of 190 μg Fluocinolone Acetonide and 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis</p>
8
Ahmed glaucoma valve in uveitic patients with fluocinolone acetonide implant-induced glaucoma: 3-year follow-up
6
Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema
10
A novel intravitreal fluocinolone acetonide implant (Iluvien<sup>®</sup>) in the treatment of patients with chronic diabetic macular edema that is insufficiently responsive to other medical treatment options: a case series
11
Efficacy and safety of sustained-delivery fluocinolone acetonide intravitreal implant in patients with chronic diabetic macular edema insufficiently responsive to available therapies: a real-life study
8
<p>Early adoption of the fluocinolone acetonide (FAc) intravitreal implant in patients with persistent or recurrent diabetic macular edema (DME)</p>
10
Post-cataract outcomes in patients with noninfectious posterior uveitis treated with the fluocinolone acetonide intravitreal implant
7
DEVELOPMENT AND EVALUATION OF FLUOCINOLONE ACETONIDE AND NEOMYCIN SULPHATE NANOMIEMGEL FOR TOPICAL DRUG DELIVERY SYSTEM
15
<p>Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes</p>
9